Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
AIMS--To identify the relative contribution of plasminogen activators, particularly tissue plasminogen activator (t-PA) and specific plasminogen activator inhibitors (PAI-1, PAI-2), to the fibrinolytic changes associated with various types of liver disease or severe chemical and physical damage to t...
Tallennettuna:
| Julkaisussa: | J Clin Pathol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
1994
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC501897/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8163691/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jcp.47.3.214 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
